Cargando…

Prostate-Specific Membrane Antigen Expression in Meningioma: A Promising Theranostic Target

Meningioma is the most common intracranial neoplasm, yet there is no effective therapy for recurrent/refractory meningiomas after surgery and radiation. Prostate-specific membrane antigen (PSMA) is an enzyme upregulated on endothelial cells of multiple neoplasms and is being investigated as a theran...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tubre, Teddi, Hacking, Sean, Alexander, Abigail, Brickman, Arlen, Delalle, Ivana, Elinzano, Heinrich, Donahue, John E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677239/ https://www.ncbi.nlm.nih.gov/pubmed/36179256 http://dx.doi.org/10.1093/jnen/nlac089

Ejemplares similares

Biomarkers in Prostate-Specific Membrane Antigen Theranostics
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2021)

Towards Personalized Treatment of Prostate Cancer: PSMA I&T, a Promising Prostate-Specific Membrane Antigen-Targeted Theranostic Agent
por: Chatalic, Kristell L.S., et al.
Publicado: (2016)

Prostate-Specific Membrane Antigen (PSMA) Theranostics for Treatment of Oligometastatic Prostate Cancer
por: Plichta, Kristin A., et al.
Publicado: (2021)

Incidental prostate-specific membrane antigen-avid meningioma detected on (68)Ga–prostate-specific membrane antigen PET/CT
por: Jiang, James Yuheng, et al.
Publicado: (2021)

Surface Modification of Liposomes by a Lipopolymer Targeting Prostate Specific Membrane Antigen for Theranostic Delivery in Prostate Cancer
por: Yari, Hooman, et al.
Publicado: (2019)

Somatostatin Receptor Theranostics for Refractory Meningiomas
por: Salgues, Betty, et al.
Publicado: (2022)

Lutetium-177 prostate-specific membrane antigen-617 theranostics: New therapeutic hope in metastatic castrate-resistant prostate cancer?
por: Ranjan, Satish Kumar
Publicado: (2020)

Prostate-specific Membrane Antigen Imaging in Recurrent Medullary Thyroid Cancer: A New Theranostic Tracer in the Offing?
por: Arora, Saurabh, et al.
Publicado: (2018)

Rationale for Prostate-Specific-Membrane-Antigen-Targeted Radionuclide Theranostic Applied to Metastatic Clear Cell Renal Carcinoma
por: Giraudet, Anne Laure, et al.
Publicado: (2023)

Navigation-assisted resection of tumoral calcinosis of the lumbosacral spine: illustrative case
por: Tang, Oliver Y., et al.
Publicado: (2022)

DARPins: Promising Scaffolds for Theranostics
por: Shilova, O. N., et al.
Publicado: (2019)

Tumor Sink Effect with Prostate-Specific Membrane Antigen-Targeted Theranostics in Patients with Metastatic Castration-Resistant Prostate Cancer: Intra-Individual Evaluations
por: Burgard, Caroline, et al.
Publicado: (2023)

PSMA-GCK01: A Generator-Based (99m)Tc/(188)Re Theranostic Ligand for the Prostate-Specific Membrane Antigen
por: Cardinale, Jens, et al.
Publicado: (2023)

Deep Membrane Proteome Profiling Reveals Overexpression of Prostate-Specific Membrane Antigen (PSMA) in High-Risk Human Paraganglioma and Pheochromocytoma, Suggesting New Theranostic Opportunity
por: Vit, Ondrej, et al.
Publicado: (2021)

Carbon nanomaterials for cardiovascular theranostics: Promises and challenges
por: Alagarsamy, Keshav Narayan, et al.
Publicado: (2021)

Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies
por: Ben Jemaa , Awatef, et al.
Publicado: (2010)

Prostate Cancer Theranostics - An Overview
por: Abou, Diane, et al.
Publicado: (2020)

Focal therapy of prostate cancer: Assessment with prostate-specific membrane antigen (PSMA) imaging
por: Topoozian, Mark, et al.
Publicado: (2023)

MicroRNA-206: a Promising Theranostic Marker
por: Novák, Jan, et al.
Publicado: (2014)

Today’s diverse nano-theranostic applications and tomorrow’s promises
por: Webster, Thomas J, et al.
Publicado: (2015)

Smart Nanoformulations for Brain Cancer Theranostics: Challenges and Promises
por: Ahmad, Faraz, et al.
Publicado: (2022)

Updates of prostate cancer staging: Prostate-specific membrane antigen
por: Sathianathen, Niranjan J, et al.
Publicado: (2016)

Prostate-specific membrane antigen-mediated theragnostics in prostate cancer
por: Jeong, Seung-hwan, et al.
Publicado: (2021)

Prostate-Specific Membrane Antigen-Based Therapeutics
por: Akhtar, Naveed H., et al.
Publicado: (2012)

The Current State of Radiomics for Meningiomas: Promises and Challenges
por: Gu, Hao, et al.
Publicado: (2020)

Prostate-specific membrane antigen is undetectable in choroidal neovascular membrane
por: Godeiro, Katyanne Dantas, et al.
Publicado: (2006)

Incidental prostate-specific membrane antigen-avid glioblastoma detected on (68)Ga–prostate-specific membrane antigen PET/CT
por: Jiang, James Yuheng, et al.
Publicado: (2022)

Current status of theranostics in prostate cancer
por: Virgolini, Irene, et al.
Publicado: (2017)

Advanced nanomaterial for prostate cancer theranostics
por: Hao, Bin, et al.
Publicado: (2022)

Globo H Is a Promising Theranostic Marker for Intrahepatic Cholangiocarcinoma
por: Hung, Tsai‐Hsien, et al.
Publicado: (2021)

Nano-Messengers of the Heart: Promising Theranostic Candidates for Cardiovascular Maladies
por: Yedavilli, Sneha, et al.
Publicado: (2022)

A Promising Approach: Magnetic Nanosystems for Alzheimer’s Disease Theranostics
por: Chaparro, Catarina I. P., et al.
Publicado: (2023)

Antigen expression on recurrent meningioma cells
por: Vranic, Andrej
Publicado: (2010)

Small-Molecule Theranostic Probes: A Promising Future in Neurodegenerative Diseases
por: Aulić, Suzana, et al.
Publicado: (2013)

Tunable Plasmonic Nanoprobes for Theranostics of Prostate Cancer
por: Lukianova-Hleb, Ekaterina Y., et al.
Publicado: (2011)

PSMA-Targeted Theranostic Nanocarrier for Prostate Cancer
por: Flores, Orielyz, et al.
Publicado: (2017)

Clinical advancement of precision theranostics in prostate cancer
por: Tan, Yue, et al.
Publicado: (2023)

Biomolecule-functionalized nanoformulations for prostate cancer theranostics
por: Pranav, et al.
Publicado: (2022)

Prostate-Specific Membrane Antigen PET Imaging in Prostate Cancer: Opportunities and Challenges
por: Oh, So Won, et al.
Publicado: (2018)

Nanobodies Targeting Prostate-Specific Membrane Antigen for the Imaging and Therapy of Prostate Cancer
por: Rosenfeld, Lior, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9f3k12h1nsiido0gequd9mjho5